Announcement
Introducing CCS’s NEW Cardiorenal Pocket Guide
June 2, 2023
The Cardiorenal Risk Reduction in Adults Pocket Guide is now here! Pocket Guides are our most popular tools due to their practicality and we are excited to include this excellent addition to the current suite.
The Cardiorenal Risk Reduction in Adults Pocket Guide is a quick reference tool full of simple algorithms to assist cardiovascular physicians on how to approach the use and integration of GLP-1 Receptor Agonists and SGLT2 Inhibitors into practice. Summary tables, including the key recommendations of the CCS Cardiorenal Guidelines and the benefits of these drug classes on cardiorenal outcomes are also included.
Interested in learning more about the CCS Cardiorenal Guidelines? Click here to view the CCS Cardiorenal Protection webinars on demand, and click here to view the Guidelines summary for healthcare providers infographic.
Other News
See AllSupport the CCS National Lipid Screening Awareness Campaign
April 12, 2024
Lipid screening is a key component of risk assessment for primary prevention of atherosclerotic...
ASCVD Cholesterol Dyslipidemia GuidelinesNew: Focused Update of the Guidelines for the Use of Antiplatelet Therapy
February 29, 2024
Under the co-chair leadership of Drs. Kevin R. Bainey and Guillaume Marquis-Gravel, the Canadian...
Antiplatelet Therapy ASCVD GuidelinesNew: The CCS/CHFS 2023 Focused Clinical Practice Update of Patients With Differing Heart Failure Phenotypes
August 8, 2023
In this clinical practice update (CPU) we aim to provide responses to fundamental questions that...
Guidelines Heart failure Phenotypes